BTI's 326th-Ranked Volume Amid Analyst Divergence and Smokeless Product Momentum Sparks Investor Uncertainty

Market Snapshot

British American Tobacco (BTI) closed on March 2, 2026, with a 0.85% decline, reflecting a negative trading session for the stock. The company’s shares traded at a volume of £0.40 billion, ranking 326th in daily trading activity on the stock market. Despite institutional investors collectively owning 16.16% of the company, the stock’s modest volume and mixed analyst sentiment—eight Buy ratings versus two Sell ratings—highlighted divergent investor perspectives. The stock’s recent performance was further contextualized by its year-to-date (YTD) return of 9.71%, outperforming the FTSE 100’s 8.55% gain, though trailing its 1-year return of 69.72%.

Key Drivers

The stock’s decline on March 2 was influenced by a mix of analyst ratings, operational updates, and institutional trading activity. UBS reiterated a Buy rating for BTI with a £52 price target, citing its undervaluation and growth potential in smokeless products, while RBC maintained a Sell rating with a £36 target, reflecting concerns over market headwinds. This divergence in analyst sentiment underscored uncertainty among investors, as the company reaffirmed its fiscal 2026 guidance, projecting revenue growth of 3-5% and adjusted profits of 4-6%.

A key operational highlight was the expansion of BTI’s smokeless product segment, which now accounts for 18.2% of group revenue—up 70 basis points from fiscal 2024. The company attributed this growth to strong U.S. performance, particularly in Velo Plus, which achieved triple-digit revenue growth. However, reported group revenue fell 1.0% to £25.61 billion due to a 3.1% currency headwind, though constant foreign exchange (FX) growth of 2.1% was driven by combustibles and smokeless products. This duality between currency-adjusted growth and nominal declines created a nuanced narrative for investors.

Institutional trading activity further shaped the stock’s trajectory. Diversify Wealth Management LLC increased its stake in BTI during Q3, acquiring 21,679 shares worth £1.14 million, while Citigroup Inc. sharply reduced its holdings by 81.9%, selling 1.7 million shares. These moves reflected divergent confidence levels in the stock’s long-term prospects. Meanwhile, the company’s dividend policy remained a draw, with a quarterly payout of £0.8349 per share (annualized £3.34), yielding 5.3% and reinforcing its appeal to income-focused investors.

The stock’s valuation also came under scrutiny. Despite its 5.3% yield and 10-year revenue CAGR of 2.1%, BTI traded at a forward P/E of 12.48 and a PEG ratio of 0.44, suggesting undervaluation relative to earnings growth. However, regulatory risks—such as potential Swiss “Too Big to Fail” reforms—loomed over UBS, a key institutional investor, which could indirectly impact BTI’s institutional ownership dynamics. Analysts emphasized that BTI’s ability to navigate currency volatility and sustain smokeless product momentum would be critical to unlocking its valuation potential.

In summary, BTI’s stock price movement was driven by a combination of analyst divergence, operational progress in smokeless products, currency-related challenges, and institutional trading patterns. While the company’s dividend yield and market share in alternative nicotine products provided a floor for investor confidence, macroeconomic and regulatory uncertainties tempered broader optimism.